CollPlant Biotechnologies (CLGN) Change in Intangibles (2020 - 2022)
CollPlant Biotechnologies (CLGN) reported Change in Intangibles of -$42000.0 for Q4 2022, up 73.91% on a YoY basis from -$24150.0 in Q4 2021, and down 223.08% quarter-over-quarter from -$13000.0 in Q3 2022.
CollPlant Biotechnologies (CLGN) Change in Intangibles (2020 - 2022) Analysis & Trends
CollPlant Biotechnologies has reported Change in Intangibles for 3 years, with the latest figure at -$42000.0 in Q4 2022.
- For the quarter ending Q4 2022, Change in Intangibles rose 73.91% year-over-year to -$42000.0; the trailing twelve-month figure through Dec 2022 stood at -$67000.0 (up 75.46% YoY), and the FY2022 full-year result was -$42000.0, up 73.91% from the prior year.
- Change in Intangibles for Q4 2022 stood at -$42000.0, down from -$13000.0 in the prior quarter.
- The five-year high for Change in Intangibles was -$6000.0 in Q1 2022, with the low at -$161000.0 in Q4 2021.
- Historically, Change in Intangibles has averaged -$46888.9 across 3 years, with a median of -$30000.0 in 2021.
- Annual changes were most pronounced in 2021 — Change in Intangibles slumped 96.34% — and 2022, when it surged 89.29%.
- CollPlant Biotechnologies' Change in Intangibles stood at -$82000.0 in 2020, then tumbled by 96.34% to -$161000.0 in 2021, then jumped by 73.91% to -$42000.0 in 2022.
- The last three Change in Intangibles figures came in at -$42000.0 (Q4 2022), -$13000.0 (Q3 2022), and -$6000.0 (Q2 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | -2.96 Mn |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | - |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | CollPlant Biotechnologies | 7.20 Mn | 7.20 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -42,000.00 |
| Dec 31, 2022 | -42,000.00 |
| Sep 30, 2022 | -13,000.00 |
| Sep 30, 2022 | -13,000.00 |
| Jun 30, 2022 | -6,000.00 |
| Jun 30, 2022 | -6,000.00 |
| Mar 31, 2022 | -6,000.00 |
| Mar 31, 2022 | -6,000.00 |
| Dec 31, 2021 | -161,000.00 |
| Dec 31, 2021 | -161,000.00 |
| Sep 30, 2021 | -30,000.00 |
| Sep 30, 2021 | -30,000.00 |
| Jun 30, 2021 | -26,000.00 |
| Jun 30, 2021 | -26,000.00 |
| Mar 31, 2021 | -56,000.00 |
| Mar 31, 2021 | -56,000.00 |
| Dec 31, 2020 | -82,000.00 |
| Dec 31, 2020 | -82,000.00 |